4//SEC Filing
SCLX Stock Acquisition JV LLC 4
Accession 0000950170-25-008463
CIK 0001820190other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 7:49 PM ET
Size
5.6 KB
Accession
0000950170-25-008463
Insider Transaction Report
Form 4
SCLX Stock Acquisition JV LLC
10% Owner
Transactions
- Other
Common Stock
2025-01-21−3,250,000→ 51,039,214 total
Footnotes (1)
- [F1]Transferred pursuant to the terms of an Amendment to Senior Secured Promissory Note (the "Amendment Letter") the Issuer and the Reporting Person entered into with Oramed Pharmaceuticals Inc. ("Oramed") for the extension of the maturity date of that certain senior secured promissory note previously issued by the Issuer to Oramed on September 21, 2023. Under the terms of the Amendment Letter and in consideration for such extension and to limit certain noteholders' rights to exercise certain secured creditor remedies (including recourse against the assets of the Reporting Person as a grantor under the Security Agreement (as defined in the Amendment Letter)), the Reporting Person transferred to Oramed an aggregate of 3,250,000 shares of common stock, par value $0.0001 per share of the Issuer, held by the Reporting Person.
Documents
Issuer
Scilex Holding Co
CIK 0001820190
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001994894
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 7:49 PM ET
- Size
- 5.6 KB